S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
NASDAQ:IMUX

Immunic Insider Trades

$5.77
+0.29 (+5.29%)
(As of 05/20/2022 04:00 PM ET)
Add
Compare
Today's Range
$5.17
$5.78
50-Day Range
$5.15
$12.25
52-Week Range
$4.96
$15.12
Volume
279,800 shs
Average Volume
286,238 shs
Market Capitalization
$176.22 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.99

Immunic (NASDAQ:IMUX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
12.07%
Number Of
Insiders Buying
(Last 12 Months)
4
Amount Of
Insider Buying
(Last 12 Months)
$125.62 K
Number Of
Insiders Selling
(Last 12 Months)
0

Insider Buying and Selling by Quarter

Get IMUX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Immunic stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Immunic (NASDAQ:IMUX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/12/2022Andreas MuehlerInsiderBuy3,500$5.10$17,850.00297,986  
5/12/2022Andreas MuehlerInsiderBuy3,500$5.10$17,850.00297,986  
5/12/2022Duane NashChairmanBuy10,000$5.03$50,300.0022,032  
5/12/2022Glenn WhaleyCFOBuy3,000$5.08$15,240.009,068  
8/10/2021Daniel VittCEOBuy1,000$9.60$9,600.0015,032  
8/10/2021Glenn WhaleyInsiderBuy1,500$9.85$14,775.003,500  
5/12/2021Duane NashChairmanBuy4,000$12.75$51,000.0014,032  
8/10/2020Glenn WhaleyInsiderBuy1,000$18.96$18,960.001,000  
7/21/2020Daniel VittCEOSell6,300$14.68$92,484.00  
7/21/2020Manfred GroeppelCOOSell5,650$14.58$82,377.00  
12/4/2019Duane NashDirectorSell4,400$6.96$30,624.0022,362  
(Data available from 1/1/2013 forward)












Immunic (NASDAQ:IMUX) Insider Trade Frequently Asked Questions

Who is on Immunic's Insider Roster?

The list of insiders at Immunic includes Andreas Muehler, Daniel Vitt, Duane Nash, Glenn Whaley, and Manfred Groeppel. Learn more on insiders at IMUX.

What percentage of Immunic stock is owned by insiders?

12.07% of Immunic stock is owned by insiders. Learn more on IMUX's insider holdings.

Which Immunic insiders have been buying company stock?

The following insiders have purchased Immunic stock in the last 24 months: Andreas Muehler ($35,700.00), Daniel Vitt ($9,600.00), Duane Nash ($101,300.00), and Glenn Whaley ($48,975.00).

How much insider buying is happening at Immunic?

Insiders have purchased a total of 27,500 Immunic shares in the last 24 months for a total of $195,575.00 bought.

Which Immunic insiders have been selling company stock?

The following insiders have sold Immunic stock in the last 24 months: Daniel Vitt ($92,484.00), and Manfred Groeppel ($82,377.00).

How much insider selling is happening at Immunic?

Insiders have sold a total of 11,950 Immunic shares in the last 24 months for a total of $174,861.00 sold.

This page was last updated on 5/23/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.